Biotec Pharmacon presents today, August 10th, at 08:00, its interim report for
the second quarter and the first half year 2011.
CEO Svein W. F. Lien, and managing director of ArcticZymes AS; Jan Buch
Please find the presentation attached.
The presentation is also available as webcast with log-on at www.biotec.no.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.